Innovation in bone healing and tissue repair
TITLE ENGLISH GERMAN
2012
Cytos Annual Report 2011
Cytos Financial Statements 2011
Cytos Q1 Report 2012
Cytos Q2 Report 2012
Cytos Q3 Report 2012

PROSPECTUS & COMPANY PRESENTATION ENGLISH GERMAN
2017
Prospectus Supplement 29 June 2017
Prospectus 16 June 2017  
Company Presentation 07 June 2017  

ANALYST REPORT ENGLISH
2016
valuationLAB: Initiation of coverage  

 

Archive

Kuros Biosciences AG
Wagistrasse 25, 8952 Schlieren, Switzerland
Tel: +41 44 733 47 47   Fax: +41 44 733 47 40   Email: info@kuros.ch

About Kuros

  1. Overview
  2. Executive Committee
  3. Board

Products

  1. Pipeline
  2. Orthobiologics
    Fracture repair
    KUR-111
    KUR-113
    MagnetOs
    Spinal fusion
    KUR-113
    MagnetOs
    Solitary Bone Cysts
    KUR-112
  3. Sealants
    Neuroseal (KUR-023)

Technologies

  1. Overview
  2. Surface Science Technology
  3. Synthetic Cross-Linking Technology
  4. Fibrin-Based
  5. Immune Modulation
  6. Publications

Partnerships

  1. Collaborations
  2. Business development

Investors

  1. Share price
  2. Regulatory filings
  3. Reports & presentations
  4. Calendar
  5. Corporate governance
  6. Stay informed

News

  1. Press releases
  2. Conferences & Events

Contact

  1. Location
Reports & presentations
TITLE ENGLISH GERMAN
2012
Cytos Annual Report 2011
Cytos Financial Statements 2011
Cytos Q1 Report 2012
Cytos Q2 Report 2012
Cytos Q3 Report 2012

PROSPECTUS & COMPANY PRESENTATION ENGLISH GERMAN
2017
Prospectus 16 June 2017  
Company Presentation 06 June 2017  

DATE ANALYST REPORT ENGLISH
2016
Jun 28, 2016 valuationLAB: Initiation of coverage  

Archive